Khalid Islam

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: Fennec Pharmaceuticals Inc., 3 years.

3 years · Since 2023
Gain Therapeutics Inc. Director · Executive Chairman
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 9, 2024 Gain Therapeutics Inc. Open-market purchase +50,000 $1.00 $50,000
Nov 16, 2023 Fennec Pharmaceuticals Inc. Option exercise +133,333 $2.31 $307,999
Nov 16, 2023 Fennec Pharmaceuticals Inc. Option exercise +10,000 $2.69 $26,900
Nov 16, 2023 Fennec Pharmaceuticals Inc. Option exercise +50,000 $1.13 $56,500
Nov 16, 2023 Fennec Pharmaceuticals Inc. Option exercise +20,492 $2.44 $50,000

Questions about Khalid Islam

What boards is Khalid Islam on?

Khalid Islam sits on the boards of Fennec Pharmaceuticals Inc. and Gain Therapeutics Inc.

How long has Khalid Islam served on boards?

Our records show at least 7 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.